Investing.com - Hims Hers Health Inc (NYSE:HIMS)股票周二早盘下跌超过3%,但在下午交易中收窄跌幅至约0.2%,此前法律风险上升和数据披露导致投资者情绪波动。最初的下跌是在诺和诺德公司(NYSE:NVO)表示正在探索诉讼和其他措施以遏制复合GLP-1药物使用之后,包括像Hims这样的平台销售的司美格鲁肽产品。 周二,诺和诺德股票下跌超过20%,因为这家...
Source LinkInvesting.com - Hims Hers Health Inc (NYSE:HIMS)股票周二早盘下跌超过3%,但在下午交易中收窄跌幅至约0.2%,此前法律风险上升和数据披露导致投资者情绪波动。最初的下跌是在诺和诺德公司(NYSE:NVO)表示正在探索诉讼和其他措施以遏制复合GLP-1药物使用之后,包括像Hims这样的平台销售的司美格鲁肽产品。 周二,诺和诺德股票下跌超过20%,因为这家...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.